Ching C K, Thompson S, Buxton C, Holgate C, Holmes G K
Department of Medicine, Derbyshire Royal Infirmary, Derby, UK.
Postgrad Med J. 1993 Jun;69(812):456-60. doi: 10.1136/pgmj.69.812.456.
Helicobacter pylori infection of the stomach is associated with gastritis and peptic ulceration and may be causative. A noninvasive test for this organism might be useful in managing some patients with dyspepsia without the need for further investigation. We have evaluated a new commercially available serological test (Helico-G ELISA, Porton Cambridge, UK) for this infection to assess its diagnostic accuracy in a retrospective study of 115 patients with non-ulcer dyspepsia. Sixty-three of these patients (55%) were found to have H. pylori infection and gastritis on histology. A sensitivity of 81% and specificity of 90% were obtained. No significant fall in the antibody titres was found in a subgroup of 15 patients who were selected to complete a course of triple therapy despite significant improvement in their dyspepsia score and confirmed eradication of H. pylori organism in 80% of these patients. We conclude that the test has limited value in aiding clinical decision of managing patients with dyspepsia.
胃部幽门螺杆菌感染与胃炎和消化性溃疡有关,可能是病因所在。针对这种微生物的非侵入性检测可能有助于管理一些消化不良患者,而无需进一步检查。我们评估了一种新的市售血清学检测方法(Helico-G ELISA,英国剑桥Porton公司)用于这种感染,以在一项对115例非溃疡性消化不良患者的回顾性研究中评估其诊断准确性。其中63例患者(55%)经组织学检查发现有幽门螺杆菌感染和胃炎。该检测的敏感性为81%,特异性为90%。在一组15例患者中,尽管他们的消化不良评分有显著改善且80%的患者经证实已根除幽门螺杆菌,但在完成三联疗法疗程后,未发现抗体滴度有明显下降。我们得出结论,该检测在辅助消化不良患者的临床管理决策方面价值有限。